Cargando…
Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119252/ https://www.ncbi.nlm.nih.gov/pubmed/34272490 http://dx.doi.org/10.1038/s41380-021-01206-x |
| _version_ | 1784710666220732416 |
|---|---|
| author | Alić, Ivan Goh, Pollyanna A. Murray, Aoife Portelius, Erik Gkanatsiou, Eleni Gough, Gillian Mok, Kin Y. Koschut, David Brunmeir, Reinhard Yeap, Yee Jie O’Brien, Niamh L. Groet, Jürgen Shao, Xiaowei Havlicek, Steven Dunn, N. Ray Kvartsberg, Hlin Brinkmalm, Gunnar Hithersay, Rosalyn Startin, Carla Hamburg, Sarah Phillips, Margaret Pervushin, Konstantin Turmaine, Mark Wallon, David Rovelet-Lecrux, Anne Soininen, Hilkka Volpi, Emanuela Martin, Joanne E. Foo, Jia Nee Becker, David L. Rostagno, Agueda Ghiso, Jorge Krsnik, Željka Šimić, Goran Kostović, Ivica Mitrečić, Dinko Francis, Paul T. Blennow, Kaj Strydom, Andre Hardy, John Zetterberg, Henrik Nižetić, Dean |
| author_facet | Alić, Ivan Goh, Pollyanna A. Murray, Aoife Portelius, Erik Gkanatsiou, Eleni Gough, Gillian Mok, Kin Y. Koschut, David Brunmeir, Reinhard Yeap, Yee Jie O’Brien, Niamh L. Groet, Jürgen Shao, Xiaowei Havlicek, Steven Dunn, N. Ray Kvartsberg, Hlin Brinkmalm, Gunnar Hithersay, Rosalyn Startin, Carla Hamburg, Sarah Phillips, Margaret Pervushin, Konstantin Turmaine, Mark Wallon, David Rovelet-Lecrux, Anne Soininen, Hilkka Volpi, Emanuela Martin, Joanne E. Foo, Jia Nee Becker, David L. Rostagno, Agueda Ghiso, Jorge Krsnik, Željka Šimić, Goran Kostović, Ivica Mitrečić, Dinko Francis, Paul T. Blennow, Kaj Strydom, Andre Hardy, John Zetterberg, Henrik Nižetić, Dean |
| author_sort | Alić, Ivan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9119252 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91192522022-05-20 Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain Alić, Ivan Goh, Pollyanna A. Murray, Aoife Portelius, Erik Gkanatsiou, Eleni Gough, Gillian Mok, Kin Y. Koschut, David Brunmeir, Reinhard Yeap, Yee Jie O’Brien, Niamh L. Groet, Jürgen Shao, Xiaowei Havlicek, Steven Dunn, N. Ray Kvartsberg, Hlin Brinkmalm, Gunnar Hithersay, Rosalyn Startin, Carla Hamburg, Sarah Phillips, Margaret Pervushin, Konstantin Turmaine, Mark Wallon, David Rovelet-Lecrux, Anne Soininen, Hilkka Volpi, Emanuela Martin, Joanne E. Foo, Jia Nee Becker, David L. Rostagno, Agueda Ghiso, Jorge Krsnik, Željka Šimić, Goran Kostović, Ivica Mitrečić, Dinko Francis, Paul T. Blennow, Kaj Strydom, Andre Hardy, John Zetterberg, Henrik Nižetić, Dean Mol Psychiatry Correction Nature Publishing Group UK 2021-07-16 2021 /pmc/articles/PMC9119252/ /pubmed/34272490 http://dx.doi.org/10.1038/s41380-021-01206-x Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correction Alić, Ivan Goh, Pollyanna A. Murray, Aoife Portelius, Erik Gkanatsiou, Eleni Gough, Gillian Mok, Kin Y. Koschut, David Brunmeir, Reinhard Yeap, Yee Jie O’Brien, Niamh L. Groet, Jürgen Shao, Xiaowei Havlicek, Steven Dunn, N. Ray Kvartsberg, Hlin Brinkmalm, Gunnar Hithersay, Rosalyn Startin, Carla Hamburg, Sarah Phillips, Margaret Pervushin, Konstantin Turmaine, Mark Wallon, David Rovelet-Lecrux, Anne Soininen, Hilkka Volpi, Emanuela Martin, Joanne E. Foo, Jia Nee Becker, David L. Rostagno, Agueda Ghiso, Jorge Krsnik, Željka Šimić, Goran Kostović, Ivica Mitrečić, Dinko Francis, Paul T. Blennow, Kaj Strydom, Andre Hardy, John Zetterberg, Henrik Nižetić, Dean Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain |
| title | Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain |
| title_full | Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain |
| title_fullStr | Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain |
| title_full_unstemmed | Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain |
| title_short | Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain |
| title_sort | correction: patient-specific alzheimer-like pathology in trisomy 21 cerebral organoids reveals bace2 as a gene dose-sensitive ad suppressor in human brain |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119252/ https://www.ncbi.nlm.nih.gov/pubmed/34272490 http://dx.doi.org/10.1038/s41380-021-01206-x |
| work_keys_str_mv | AT alicivan correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT gohpollyannaa correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT murrayaoife correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT porteliuserik correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT gkanatsioueleni correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT goughgillian correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT mokkiny correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT koschutdavid correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT brunmeirreinhard correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT yeapyeejie correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT obrienniamhl correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT groetjurgen correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT shaoxiaowei correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT havliceksteven correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT dunnnray correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT kvartsberghlin correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT brinkmalmgunnar correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT hithersayrosalyn correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT startincarla correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT hamburgsarah correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT phillipsmargaret correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT pervushinkonstantin correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT turmainemark correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT wallondavid correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT roveletlecruxanne correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT soininenhilkka correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT volpiemanuela correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT martinjoannee correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT foojianee correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT beckerdavidl correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT rostagnoagueda correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT ghisojorge correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT krsnikzeljka correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT simicgoran correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT kostovicivica correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT mitrecicdinko correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT francispault correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT blennowkaj correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT strydomandre correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT hardyjohn correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT zetterberghenrik correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain AT nizeticdean correctionpatientspecificalzheimerlikepathologyintrisomy21cerebralorganoidsrevealsbace2asagenedosesensitiveadsuppressorinhumanbrain |